Inventergy Global 10-Q 13 Nov 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 08, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Entity Registrant Name	Inventergy Global, Inc.
Entity Central Index Key	1,084,752
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	INVT
Entity Common Stock, Shares Outstanding		18,984,348

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 2,878	$ 1,476,774
Accounts receivable	5,994	20,818
Prepaid expenses and other current assets	509,377	978,371
Deferred expenses, current	0	97,409
Total current assets	518,249	2,573,372
Property and equipment, net	0	8,260
Patents, net	0	7,158,941
Intangible assets, net	0	273,083
Investment in INVT SPE LLC	42,962,899	0
Goodwill	0	8,858,504
Deposits and other assets	20,858	18,993
Total assets	43,502,006	18,891,153
Current liabilities
Accounts payable	2,007,288	1,639,630
Accrued expenses and other current liabilities	566,986	172,441
Short-term loan payable, related parties	530,000	0
Guaranteed payments, current	2,200,000	2,200,000
Senior notes payable, current	0	8,144,306
Deferred revenue	0	400,000
Total current liabilities	5,304,274	12,556,377
Deferred revenue, non-current	0	846,429
Senior revenue share, net of discount	0	3,948,153
Total liabilities	5,304,274	17,350,959
Commitments and Contingencies (Note 7)
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized, 18,607,779 shares and 11,532,235 shares issued and outstanding at September 30, 2017 and December 31, 2016	18,608	11,532
Additional paid-in capital	64,856,587	64,532,323
Accumulated deficit	(26,677,465)	(63,003,664)
Total stockholders' equity	38,197,732	1,540,194
Total liabilities and stockholders' equity	43,502,006	18,891,153
Series C Convertible Preferred Stock [Member]
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized	0	0
Series D Convertible Preferred Stock [Member]
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized	0	0
Series E Convertible Preferred Stock [Member]
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized	$ 2	$ 3

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	18,607,779	11,532,235
Common Stock, Shares, Outstanding	18,607,779	11,532,235
Series C Convertible Preferred Stock [Member]
Preferred stock shares designated	2,500	2,500
Preferred stock, shares issued	5	5
Preferred stock, shares outstanding	5	5
Temporary equity, liquidation preference	$ 5,000	$ 5,000
Series D Convertible Preferred Stock [Member]
Preferred stock shares designated	1,500	1,500
Preferred stock, shares issued	369	369
Preferred stock, shares outstanding	369	369
Temporary equity, liquidation preference	$ 369,000	$ 369,000
Series E Convertible Preferred Stock [Member]
Preferred stock shares designated	3,000	3,000
Preferred stock, shares issued	2,076	3,000
Preferred stock, shares outstanding	2,076	3,000
Temporary equity, liquidation preference	$ 2,076,000	$ 3,000,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenues	$ 0	$ 106,095	$ 1,256,608	$ 1,674,275
Operating Expenses
Cost of revenues	0	35,736	370,492	356,750
Patent amortization expense	0	377,746	503,660	1,133,235
General and administrative	711,047	1,620,311	2,788,060	5,006,810
Total operating expenses	711,047	2,033,793	3,662,212	6,496,795
Loss from operations	(711,047)	(1,927,698)	(2,405,604)	(4,822,520)
Other income (expense)
Gain on debt extinguishment	0	0	40,802,730	2,434,661
Decrease in fair value of derivative liabilities	0	330	0	948
Interest expense, net	(97,385)	(867,713)	(2,070,927)	(2,867,741)
Total other income (expense), net	(97,385)	(867,383)	38,731,803	(432,132)
Net income (loss)	(808,432)	(2,795,081)	36,326,199	(5,254,652)
Deemed dividend on preferred stock	0	0	0	(466,667)
Net income (loss) attributable to common shareholders	$ (808,432)	$ (2,795,081)	$ 36,326,199	$ (5,721,319)
Basic income (loss) per share	$ (0.05)	$ (0.57)	$ 2.61	$ (1.26)
Fully diluted income (loss) per share	$ (0.05)	$ (0.57)	$ 0.67	$ (1.26)
Weighted average shares outstanding:
Basic	16,868,702	4,910,740	13,911,880	4,529,568
Fully diluted	16,868,702	4,910,740	54,184,893	4,529,568

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities
Net income (loss)	$ 36,326,199	$ (5,254,652)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation expense	8,260	12,753
Gain on debt extinguishment	(40,802,730)	(2,434,661)
Decrease in fair value of derivative liabilities	0	(948)
Amortization of discount on notes payable	1,261,156	2,064,774
Accrued interest on patents purchased	198,000	123,233
Amortization of patents and acquired contracts	776,745	1,217,985
Stock-based compensation	334,796	545,626
Changes in operating assets and liabilities
Accounts receivable	14,824	8,880
Prepaid expenses and other current assets	440,518	(646,943)
Deferred expenses	97,409	(27,391)
Deposits and other assets	(1,865)	0
Accounts payable	367,658	777,559
Accrued expenses and other current liabilities	221,563	407,267
Deferred revenue	(1,246,429)	450,000
Net cash used in operating activities	(2,003,896)	(2,756,518)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of issuance costs	0	5,221,998
Proceeds from issuance of common stock, net of issuance costs	0	1,182,278
Proceeds from short-term notes payable, related parties	530,000	0
Payments on senior notes payable	0	(1,640,016)
Redemption of preferred stock	0	(2,500,000)
Payments on related party note payable	0	(50,000)
Net cash provided by financing activities	530,000	2,214,260
Net decrease in cash and cash equivalents	(1,473,896)	(542,258)
Cash and cash equivalents, beginning of period	1,476,774	554,556
Cash and cash equivalents, end of period	2,878	12,298
Supplemental disclosures of cash flow information
Cash paid for interest	0	613,600
Supplemental disclosures of non-cash investing and financing activities
Fair value of common stock warrants	$ 341,535	$ 4,154,620

Organization

Organization	9 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	1. Organization Inventergy Global, Inc. (“Inventergy,” “Company,” “we,” “us,” or “our”) is an intellectual property (“IP”) investment and licensing company that works with technology-leading corporations in attaining greater value from their IP assets in support of their business objectives and corporate brands. Our original monetization and licensing business was enhanced in April 2016, when the Company formed Inventergy Innovations, LLC (“Inventergy Innovations”) as a majority-owned subsidiary of the Company. The Company has two distinct business execution approaches to achieve monetization of IP: · Inventergy Innovations: Commercialization of a broad range of intellectual assets and innovations through which Inventergy Innovations obtains exclusive rights to IP owned by its partners, and · Patent Residual Interest Program (“PRIP”): Monetization through enforcement of the 740 telecommunications patents previously owned by the Company (“the Patents”) which were transferred to INVT SPE LLC (“INVT SPE”) in April 2017 as more fully explained in Note 3. In addition, the Company has an access control and security product/service business which provides royalty revenue based on the sale of such products under a licensing agreement (“ECS” or “the ECS business”). The Company’s two core strategies are to (1) commercialize IP by establishing partnerships with companies that have developed or acquired IP with potential applications in large, growing markets, and (2) assist the Managing Member of INVT SPE as needed with the monetization efforts for the Patents under the PRIP, sharing in the proceeds of such efforts after monetization costs and other contractual and priority payments are covered. Inventergy, Inc. was initially organized as a Delaware limited liability company under the name Silicon Turbine Systems, LLC in January 2012. It subsequently changed its name to Inventergy, LLC in March 2012 and it was converted from a limited liability company into a Delaware corporation in February 2013. On June 6, 2014, a subsidiary of eOn Communications Corporation (“eOn”) merged with and into Inventergy, Inc. (the “Merger”). As a result of the Merger, eOn changed its name to “Inventergy Global, Inc.” The Company is headquartered in Cupertino, California. The Company operates in a single industry segment.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies The financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements as of December 31, 2016 included in the Company’s Annual Report on Form 10-K filed on March 31, 2017. It is management’s opinion that all adjustments necessary for a fair presentation of the results for the interim periods have been made, and all such adjustments were of a normal recurring nature. In accordance with ASU No. 2014-15 Presentation of Financial Statements – Going Concern (Subtopic 205-40), At September 30, 2017, the Company has an accumulated deficit since inception of $ 26,677,465 4,686,026 7.55 363,000 1,126,900 1.5 8.1 The transfer of the Patents to INVT SPE under the PRIP, which was completed in April 2017, resulted in the net book value of the Patents being removed from our balance sheet as of April 30, 2017. In addition, the Senior Notes (as defined below) and revenue share liabilities were extinguished as of that date. The net impact on liquidity from these transactions was a decrease in interest expense, a decrease in patent maintenance costs, and a decrease in legal fees. However, the business will need additional capital and/or revenues to continue to execute the Company’s business plan, which will be used to fund operating expenses and Inventergy Innovations partner acquisition expenses. Based on the Company’s internal planning for 2017 and 2018, which anticipates certain cash inflows and revenue from the Inventergy Innovations commercialization deal pipeline expected to close during 2018 and beyond, estimated cash expenditures for operating expenses will be approximately $ 3.2 1.9 0.2 1.1 The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. Although these estimates reflect management's best estimates, it is at least reasonably possible that a material change to these estimates could occur in the near term. The Company considers all highly liquid financial instruments with original maturities of three months or less at the time of purchase to be cash equivalents. Accounts receivable are stated net of allowances for doubtful accounts. The Company typically grants standard credit terms to customers in good credit standing. The Company generally reserves for estimated uncollectible accounts on a customer-by-customer basis, which requires judgment about each individual customer’s ability and intention to fully pay account balances. The Company makes these judgments based on knowledge of and relationships with customers and current economic trends, and updates estimates on a monthly basis. Any changes in estimate, which can be significant, are included in earnings in the period in which the change in estimate occurs. As of September 30, 2017 and December 31, 2016, the Company has not established any reserves for uncollectable accounts. Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets (or the term of the lease, if shorter), which range from three to five years. Routine maintenance and repair costs are expensed as incurred. The costs of major additions, replacements and improvements are capitalized. Upon retirement, sale or disposal, the cost of assets disposed of and the related accumulated depreciation is removed and any resulting gain or loss is credited or charged to operations. As of December 31, 2016, intangible assets consisted of certain contract rights acquired in the Merger, and were being amortized on a straight-line basis over their estimated useful life of five years. As of June 30, 2017, the remaining balance of intangible assets was written off due to declining revenue from these contract rights. The Company evaluates the carrying value of long-lived assets on an annual basis, or more frequently whenever circumstances indicate a long-lived asset may be impaired. When indicators of impairment exist, the Company estimates future undiscounted cash flows attributable to such assets. In the event cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair value. As mentioned in the previous paragraph, intangible assets were written off in the three-month period ended June 30, 2017. Also, as explained more fully in Note 3, goodwill and the remaining net book value of patent assets were written off in the three-month period ended June 30, 2017 as part of a debt extinguishment. Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents are deposited with high quality financial institutions. Periodically, such balances are in excess of federally insured limits. The Company has not experienced any losses due to concentration of credit risk. The Company has a stock option plan under which incentive and non-qualified stock options and restricted stock awards (“RSAs”) are granted primarily to employees. All share-based payments to employees, including grants of employee stock options and RSAs, are recognized in the financial statements based on their respective grant date fair values. The benefits of tax deductions in excess of recognized compensation cost are reported as an operating cash flow. The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods in the Company’s statements operations. The Company has estimated the fair value of each option award as of the date of grant using the Black-Scholes option pricing model. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded. The awards issued consist of fully-vested stock awards, performance-based restricted shares, and service-based restricted shares. Expenses related to stock-based awards issued to non-employees are recognized at fair value on a recurring basis over the expected service period. The Company estimates the fair value of the awards using the Black-Scholes option pricing model. The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability account balances are determined based on temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future pretax earnings, the reversal of temporary differences between book and tax income, and the expected tax rates in future periods. The Company has a full valuation allowance on all deferred tax assets. The Company is required to evaluate the tax positions taken in the course of preparing its tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount that is initially recognized. In February 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-02, "Leases (Topic 842)". The amendments under this pronouncement will change the way all leases with a duration of one year of more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized like capital leases are under current accounting standards, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. This update is effective for annual reporting periods, and interim periods within those reporting periods, beginning after December 15, 2018. The Company is currently evaluating the impact this standard will have on its policies and procedures pertaining to its existing and future lease arrangements, disclosure requirements and on its consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (Topic 350), which eliminates Step 2 from the goodwill impairment test. Instead, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The Company will adopt the standard effective October 1, 2020. The adoption is not expected to have a material impact on the Company’s consolidated financial statements. In May 2014, the FASB issued a new financial accounting standard which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. ASU 2014-09 Revenue from Contracts with Customers In November 2016, the FASB issued Accounting Standards Update (ASU) 2016-18, Statement of Cash Flows In March 2016, the FASB issued Accounting Standards Update (ASU) 2016-09, Improvements to Employee Share-Based Payment Accounting

Prior Borrowing Arrangements an

Prior Borrowing Arrangements and Restructuring Agreement	9 Months Ended
	Sep. 30, 2017
Prior Borrowing Arrangements and Restructuring Agreement [Abstract]
Prior Borrowing Arrangements and Restructuring Agreement	3. Prior Borrowing Arrangements and Restructuring Agreement On October 1, 2014, the Company and its wholly-owned subsidiary, Inventergy, Inc., entered into the Revenue Sharing and Note Purchase Agreement with DBD Credit Funding, LLC (the “Senior Lender”). On February 25, 2015, the Company, Inventergy, Inc. and the Senior Lender entered into the Amended and Restated Revenue Sharing and Note Purchase Agreement (the “Senior Debt Agreement”). Pursuant to the Senior Debt Agreement, the Company issued an aggregate of $ 12,199,500 50,000 11,137,753 476,868 LIBOR plus 7% (total interest rate of approximately 8.7% while the loan was outstanding). In addition, a 3% per annum paid-in-kind (“PIK”) interest was accrued increasing the principal amount of the Senior Notes by the amount of such interest. The PIK interest was treated as principal of the Senior Notes for all purposes of interest accrual or calculation of any premium payment. In connection with the execution of the Senior Debt Agreement, the Company paid to the Senior Lender a structuring fee equal to $385,000, which was accounted for as a discount on notes payable. In December 2016, the Company and the Senior Lender and CF DB EZ LLC (the “Managing Member”) entered into a Restructuring Agreement (the “Restructuring Agreement”) to further amend the Senior Debt Agreement. Among other terms, the Restructuring Agreement required the Company to transfer 740 telecommunications patents to a special purpose entity, as discussed in detail below. Pursuant to the Restructuring Agreement, the Managing Member has the sole discretion to make any and all decisions relating to the transferred patents and patent monetization activities (excluding future acquired patents related to Inventergy Innovations, LLC, a subsidiary of Parent, and related monetization activities), including the right to license, sell or sue unauthorized users of the Patents (the “Monetization Activities”). In addition, the Restructuring Agreement modifies the revenue share provided for in the Senior Debt Agreement such that all proceeds from the Monetization Activities will be applied as follows: (i) first, to pay for certain third party expenses incurred by the Company, the Managing Member or third party brokers in relation to the Monetization Activities, (ii) second, to pay up to $2.2 million of the Company’s outstanding principal debt to a third party from whom the Company previously purchased certain Patents, in the event any Monetization Activity is directly attributable to those certain Patents, (iii) third, if a Monetization Activity triggers a payment with respect to a retained interest owed to a party from whom the Company originally purchased the Patents, payment will be made to such prior owner, as required, (iv) fourth, to the Managing Member until the Managing Member has received (x) reimbursement of any amounts advanced by the Managing Member pursuant to the Restructuring Agreement plus 20% annual interest on such advances plus (y) $30.5 million less any amounts paid to the Managing Member for the note obligations under the Senior Debt Agreement after December 22, 2016, and (v) fifth, after all of the foregoing payment obligations are satisfied, 70% to the Managing Member and 30% to the Company. The Restructuring Agreement required that the Company obtain stockholder approval and consents of third parties to the assignment of the Patents to INVT SPE, the newly created special purpose entity. Stockholder approval was obtained at a special meeting of stockholders on March 8, 2017 and in April 2017 the Company completed all requirements under the Restructuring Agreement and the Patents were transferred to INVT SPE. INVT SPE is managed by the Managing Member, and the economic arrangements provided for under the Restructuring Agreement are reflected in the governing documents for INVT SPE. Upon the transfer of the Patents to INVT SPE, the Senior Notes and the revenue share liabilities were extinguished, the Company was relieved of any scheduled amortization (instead, payments to the Senior Lender will only be required out of Monetization Revenues), the liquidity covenant no longer applies, and the Company has been relieved from any further responsibility to maintain the Patents, retroactive to December 22, 2016. Based on these terms and the consideration exchanged, this transaction was accounted for as an extinguishment of debt, and as of the effective date of the Restructuring Agreement (April 30, 2017), the Company recorded a gain on debt extinguishment of $ 40,802,730 Elimination of Senior Notes $ 9,405,462 Elimination of Senior Revenue Share 3,948,153 Elimination of carrying value of Patents (6,665,280) Elimination of goodwill (8,858,504) Establishment of Investment in INVT SPE 42,962,899 Gain on debt extinguishment $ 40,802,730 The initial carrying value of investment in INVT SPE was established by an independent, third-party valuation firm, using the income approach and modeling the net discounted future licensing revenue opportunity in the three primary market segments currently targeted by INVT SPE. The valuation also employed the market approach in the derivation of royalty rates used to arrive at projected revenues. Also, as part of the accounting for the debt extinguishment, the Company wrote-off goodwill in the amount of $ 8,858,504 The Restructuring Agreement is subject to certain events of default, including, among other things, liquidation or dissolution, change of control, bankruptcy, the Company’s failure to make payments pursuant to the terms of the Restructuring Agreement or the Company’s failure to perform or observe certain covenants. Upon the occurrence of an event of default, the Senior Lender may proceed to protect and enforce its rights through seeking the Company’s specific performance of any covenant or condition, as set forth in the Restructuring Agreement, or may declare the remaining unpaid balance owed under the Senior Debt Agreement, as amended, and any other amounts owed pursuant to the Restructuring Agreement to be immediately due and payable.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2017
Stockholders Equity Note [Abstract]
Stockholders' Equity	4. Stockholders’ Equity Common stock The Company is authorized to issue up to 110,000,000 100,000,000 10,000,000 On October 12, 2016, the Company completed a registered public offering (the “Offering”) of shares of common stock and warrants with gross proceeds of $ 6.0 6,000,000 1.00 6,000,000 1.00 5.1 1.3 3.8 3.8 1.43 1.86 15 On May 16, 2016, the Company entered into a securities purchase agreement (the “2016 Purchase Agreement”) with certain investors (the “2016 Purchasers”) pursuant to which the Company sold 648,000 2.005 1.3 100 2.005 116,932 Series C Convertible Preferred Stock 3,335 Series D Convertible Preferred Stock 186,367 Series E Convertible Preferred Stock 24,364,518 Options to purchase common stock 487,528 Shares reserved for issuances pursuant to 2014 Plan (as defined below) 202,290 Warrants 11,615,849 Total 36,859,887 Convertible preferred stock Convertible Original Shares Shares Shares Liquidation Preferred Stock Issue Price Designated Originally Issued Outstanding Preference Series C $ 1,000.00 2,500 2,500 5 $ 5,000 Series D $ 1,000.00 750 369 369 $ 369,000 Series E $ 1,000.00 3,000 3,000 2,076 $ 2,076,000 On January 21, 2016, the Company entered into a securities purchase agreement (the “Series C Purchase Agreement”) with certain institutional accredited investors (the “Series C Investors”). Pursuant to the Series C Purchase Agreement, the Company sold to the Series C Investors in a private placement 2,500 1,000 2.5 1,666,668 1.50 466,667 2,474 3,837,400 1,363,400 21 Each Series C Investor also received a common stock purchase warrant (the “Series C Warrants”) to purchase up to a number of shares of common stock equal to 85 1.50 1,416,668 1.79 The Series C Purchase Agreement required the Company to hold a special meeting of stockholders to seek the approval of the holders of its common stock for the issuance of the number of shares of common stock issuable upon the conversion of the Series C Preferred Stock in excess of 19.99% of the outstanding common stock and the removal of the adjustment floor within 120 days of the execution of the Series C Purchase Agreement. The Company obtained the requisite shareholder approval on June 28, 2016. Additionally, until the Series C Preferred Stock is no longer outstanding, the Series C Investors may participate in future offerings for up to 50% of the amount of such offerings. The Company utilized a placement agent who received a commission equal to 10 250,000 25,000 50,000 On May 13, 2016, the Company entered into, and consummated the transactions contemplated by, a securities purchase agreement (the “Series D Purchase Agreement”) with certain accredited investors (the “Series D Investors”). Pursuant to the Series D Purchase Agreement, the Company sold to the Series D Investors, in a private placement, 369 1,000 369,000 144,000 The Series D Preferred Stock is immediately convertible into shares of the Company’s common stock, subject to certain beneficial ownership limitations, at an initial conversion price equal to $ 1.98 The Company may redeem some or all of the Series D Preferred Stock for cash in an amount equal to 135% of the aggregate stated value then outstanding. Each Series D Investor also received a common stock purchase warrant (the “Series D Warrants”) to purchase up to a number of shares of common stock equal to 85 1.87 On July 21, 2016, the Company entered into an agreement (the “Series E Purchase Agreement”) to sell $ 3.0 3,000 1,000 3.0 1,496,262 2.005 The Company used part of the proceeds from the sale of Series E Preferred Stock to redeem 70% of the outstanding Series C Preferred Stock. In addition, pursuant to the terms of the Series E Purchase Agreement, each of the Series C Investors was entitled to receive an additional premium such that the aggregate redemption amount is 162% of the stated value of the Series C Preferred Stock for the first 60 days after the date of the Series E Purchase Agreement and 180% thereafter. Following subsequent amendments to the Series E Purchase Agreement, the Series E Preferred Stock is redeemable at the option of the Company at 170% of the then outstanding conversion amount, and is convertible into common stock at a conversion price equal to the lesser of (a) $2.005 per share, or (b) 65% of the volume weighted average price of our common stock for ten consecutive days prior to the applicable conversion date). The Series E Purchase Agreement required the Company to hold a special meeting of stockholders to seek the approval of the holders of its common stock for the issuance of the number of shares of common stock issuable upon the conversion of the Series E Preferred Stock in excess of 19.99% of the outstanding common stock within 120 days of the execution of the Series E Purchase Agreement. The Company obtained the requisite shareholder approval on March 8, 2017. On January 25, 2017, the Company entered into an amendment (the “Series E Amendment”) to the Series E Purchase Agreement, with each of the holders of the Series E Preferred Stock. Pursuant to the Series E Amendment, the Company (i) extended the date for redemption by the Company of the Series E Preferred Stock from January 25, 2017 until March 8, 2017; (ii) increased the optional redemption amount payable to the holders of the Series E Preferred Stock after January 25, 2017 from 165 170 5.5 1,000,000 0.60 On March 8, 2017, the Company entered into a lock-up agreement with each of the holders of the Series E Preferred Stock of the Company (the “Series E Stockholders”) pursuant to which the Series E Stockholders agreed not to sell any common stock obtained upon conversion of the Series E Preferred Stock, until after March 31, 2017, for less than $ 0.50 On July 26, 2017, the Company entered into an Exchange Right and Leak-Out Agreement with holders of the Series E Preferred Stock. Pursuant to the agreement, in lieu of the conversion right as provided in the Certificate of Designation of Preferences, Rights and Limitations of the Series E Preferred Stock, each holder has the right to exchange its shares (the “Shares”) of Series E Preferred Stock for shares (the “Exchange Shares”) of the Company’s common stock at an exchange rate so that for each Share, the holder will receive a number of Exchange Shares that would yield net proceeds of $ 1,350 The holders also agreed to not sell the Exchange Shares in an amount that would exceed the greater of (a) a percentage of the total trading volume on any given day and (b) $500, with an aggregate limit of 25% of total trading volume among all holders. Any sale of Exchange Shares at a price of more than $0.20 per share (the “Break-out Price”) is not subject to the agreement. The Break-out Price may be further reduced if the Company does not meet certain requirements under the agreement. During the three months ended September 30, 2017, a total of 182 3,470,762 Warrants Warrants Remaining Contractual Weighted Average Outstanding Life (years) Exercise 1,000,000 5.89 $ 0.600 6,000,000 4.03 $ 1.000 1,000,000 5.89 $ 2.005 1,271,826 3.81 $ 2.005 648,000 3.63 $ 2.01 158,416 3.62 $ 1.87 1,416,668 3.31 $ 1.79 50,000 4.41 $ 2.54 10,870 2.52 $ 4.60 5,762 2.52 $ 5.75 27,449 2.37 $ 20.00 23,858 1.33 $ 22.70 3,000 0.08 $ 26.60 11,615,849 4.20 $ 1.43

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2017
Workers Compensation Discount [Abstract]
Stock-Based Compensation	5. Stock-Based Compensation In November 2013, the Board of Directors authorized the 2013 Stock Plan (such plan has since been adopted by the stockholders of the Company in connection with the Merger and renamed the “Inventergy Global, Inc. 2014 Stock Plan”, the “Plan” or the “2014 Plan”). Under the Plan, the Board of Directors may grant incentive stock awards to employees and directors, and non-statutory stock options to employees, directors and consultants as well as restricted stock. The Plan provides for the grant of stock options, restricted stock, and other stock-related and performance awards that may be settled in cash, stock, or other property. The Board of Directors originally reserved 360,545 170,000 250,000 Options and RSAs Outstanding Shares Available Number of Weighted Average Exercise for Grant Shares Price Per Share Balance at December 31, 2016 175,046 514,772 $ 2.77 Options granted - - $ - Options forfeited - - $ - Options expired 27,244 (27,244) $ 15.80 Balance at September 30, 2017 202,290 487,528 $ 2.04 Total vested and expected to vest shares (options) 487,528 $ 2.04 Total vested shares (options) 280,742 $ 2.37 As of September 30, 2017, all of the restricted stock granted under the Plan had vested. The aggregate intrinsic value of stock options outstanding, stock options vested and expected to vest, and exercisable at September 30, 2017 was zero, since all of the options were out-of-the-money at September 30, 2017. Prior to the Plan being established, the Company granted the equivalent of 1,413,904 148,144 113,388 Options Outstanding Options Vested Weighted- Weighted- Average Weighted- Average Exercise Remaining Average Exercise Price Per Shares Contractual Exercise Shares Price Per Share Outstanding Life (Years) Price Exercisable Share $ 1.41 305,000 8.81 $ 1.41 120,840 $ 1.41 $ 3.10 182,528 7.48 $ 3.10 159,902 $ 3.10 487,528 8.31 $ 2.04 280,742 $ 2.37 There were no stock options granted during the nine months ended September 30, 2017. For the nine months ended September 30, 2016, the fair value of employee stock options granted was estimated using the following weighted-average assumptions: Expected volatility 68 % Risk free rate 1.18 % Dividend yield 0 % Expected term (in years) 5.70 The expected term of the options was based on the average period the stock options are expected to remain outstanding based on the option’s vesting term and contractual terms. The expected stock price volatility assumptions for the Company’s stock options were determined by examining the historical volatilities for the Company and industry peers. The risk-free interest rate assumption was based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption was based on the Company’s history and expectation of dividend payouts. Forfeitures were estimated based on the Company’s estimate of future cancellations. Stock-based compensation for employees and non-employees related to options and RSAs recognized: For the three months ended Sept. 30 For the nine months ended Sept. 30 2017 2016 2017 2016 General and administrative $ 85,776 $ 152,170 $ 334,797 $ 545,626 No income tax benefit has been recognized related to stock-based compensation expense and no tax benefits have been realized from exercised stock awards. As of September 30, 2017, there were total unrecognized compensation costs of $ 166,562 1.15 Non-employee stock-based compensation expense The Company previously issued options and restricted stock awards to non-employees in exchange for services with vesting specific to each individual award. Non-employee stock-based compensation expense is recognized as the awards vest and totaled $ 21,638 77,672 133,935 297,693

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	6. Income Taxes On a quarterly basis, the Company records income tax expense or benefit based on year-to-date results and expected results for the remainder of the year. The Company recorded no provision for income taxes for the three- and nine-month periods ended September 30, 2017 and 2016. Deferred income taxes reflect the tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Based on the Company’s historical net losses during its development stage, the Company has provided a full valuation allowance against its deferred tax assets as of September 30, 2017 and 2016. At December 31, 2016, the Company had federal and California net operating loss carryforwards, prior to any annual limitation, of approximately $ 55.5 11.1 30.4 9.6 5.5 The Company files income tax returns in the U.S. and various state jurisdictions including California. In the normal course of business, the Company is subject to examination by taxing authorities including the United States and California. The Company is not currently under audit or examination by either of these jurisdictions. The federal and California statute of limitations remains open back to 2011 for federal and 2010 for California. However, due to the fact that the Company has net operating losses carried forward dating back to 2001, certain items attributable to technically closed years are still subject to adjustment by the relevant taxing authority through an adjustment to the tax attributes carried forward to open years.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	7. Commitments and Contingencies Operating lease In July 2017, the Company vacated its offices in Campbell, California and signed a six-month lease for office space in Cupertino, California effective August 1, 2017 which requires lease payments of $ 1,767 Rent expense was $ 11,691 65,994 81,455 Guaranteed payments The Company entered into an agreement to purchase certain patent assets under which guaranteed payments were required. This agreement originally required a $ 2,000,000 550,000 1,650,000 2,200,000 10 Nasdaq Listing Previously, on November 21, 2016 and on , the Company received notice from The NASDAQ Stock Market (“Nasdaq”) indicating that, because the closing bid price for the Company’s common stock had fallen below $ 1.00 Bid Price Requirement”) and 2,500,000 for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) and . The Company subsequently submitted a notice of appeal to Nasdaq appealing its determination that the Company no longer complied with the Stockholders’ Equity Requirement, which appeal was heard before a hearings panel (the “Panel”) on June 1, 2017. On May 23, 2017, the Company received notice from Nasdaq that the Company had not regained compliance with the Minimum Bid Price Requirement, which serves as an additional basis for delisting the Company’s common stock from the Nasdaq Capital Market On June 5, 2017, the Company received notice from Nasdaq that the Panel has determined to delist the shares of the Company from the Nasdaq Stock Market and will suspend trading in the Company’s shares effective at the open of business on June 7, 2017. The Company submitted a request to the Office of Appeals and Review on June 20, 2017, requesting that the Nasdaq Listing and Hearing Review Council (the “Council”) review the Panel’s decision. On July 28, 2017, the Company updated the Council regarding the third party independent valuation that was undertaken to establish the value of INVT SPE and the resulting positive impact on the Company’s stockholders’ equity. On August 29, 2017, the Company received a notice from Nasdaq stating that it had determined that the Company had failed to comply with Nasdaq’s shareholder approval requirement set forth in Listing Rule 5635(d), which requires shareholder approval of any issuance of shares of common stock greater than 20

Summary of Significant Accoun13

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements as of December 31, 2016 included in the Company’s Annual Report on Form 10-K filed on March 31, 2017. It is management’s opinion that all adjustments necessary for a fair presentation of the results for the interim periods have been made, and all such adjustments were of a normal recurring nature.
Liquidity and Capital Resources	Liquidity and Capital Resources In accordance with ASU No. 2014-15 Presentation of Financial Statements – Going Concern (Subtopic 205-40), At September 30, 2017, the Company has an accumulated deficit since inception of $ 26,677,465 4,686,026 7.55 363,000 1,126,900 1.5 8.1 The transfer of the Patents to INVT SPE under the PRIP, which was completed in April 2017, resulted in the net book value of the Patents being removed from our balance sheet as of April 30, 2017. In addition, the Senior Notes (as defined below) and revenue share liabilities were extinguished as of that date. The net impact on liquidity from these transactions was a decrease in interest expense, a decrease in patent maintenance costs, and a decrease in legal fees. However, the business will need additional capital and/or revenues to continue to execute the Company’s business plan, which will be used to fund operating expenses and Inventergy Innovations partner acquisition expenses. Based on the Company’s internal planning for 2017 and 2018, which anticipates certain cash inflows and revenue from the Inventergy Innovations commercialization deal pipeline expected to close during 2018 and beyond, estimated cash expenditures for operating expenses will be approximately $ 3.2 1.9 0.2 1.1 The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.
Management estimates and related risks	Management estimates and related risks The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. Although these estimates reflect management's best estimates, it is at least reasonably possible that a material change to these estimates could occur in the near term.
Cash and cash equivalents	Cash and cash equivalents The Company considers all highly liquid financial instruments with original maturities of three months or less at the time of purchase to be cash equivalents.
Accounts Receivable, net	Accounts Receivable Accounts receivable are stated net of allowances for doubtful accounts. The Company typically grants standard credit terms to customers in good credit standing. The Company generally reserves for estimated uncollectible accounts on a customer-by-customer basis, which requires judgment about each individual customer’s ability and intention to fully pay account balances. The Company makes these judgments based on knowledge of and relationships with customers and current economic trends, and updates estimates on a monthly basis. Any changes in estimate, which can be significant, are included in earnings in the period in which the change in estimate occurs. As of September 30, 2017 and December 31, 2016, the Company has not established any reserves for uncollectable accounts.
Property and equipment, net	Property and equipment Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets (or the term of the lease, if shorter), which range from three to five years. Routine maintenance and repair costs are expensed as incurred. The costs of major additions, replacements and improvements are capitalized. Upon retirement, sale or disposal, the cost of assets disposed of and the related accumulated depreciation is removed and any resulting gain or loss is credited or charged to operations.
Intangible Assets	Intangible Assets As of December 31, 2016, intangible assets consisted of certain contract rights acquired in the Merger, and were being amortized on a straight-line basis over their estimated useful life of five years. As of June 30, 2017, the remaining balance of intangible assets was written off due to declining revenue from these contract rights.
Impairment of long-lived assets	Impairment of long-lived assets The Company evaluates the carrying value of long-lived assets on an annual basis, or more frequently whenever circumstances indicate a long-lived asset may be impaired. When indicators of impairment exist, the Company estimates future undiscounted cash flows attributable to such assets. In the event cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair value. As mentioned in the previous paragraph, intangible assets were written off in the three-month period ended June 30, 2017. Also, as explained more fully in Note 3, goodwill and the remaining net book value of patent assets were written off in the three-month period ended June 30, 2017 as part of a debt extinguishment.
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents are deposited with high quality financial institutions. Periodically, such balances are in excess of federally insured limits. The Company has not experienced any losses due to concentration of credit risk.
Stock-based compensation	Stock-based compensation The Company has a stock option plan under which incentive and non-qualified stock options and restricted stock awards (“RSAs”) are granted primarily to employees. All share-based payments to employees, including grants of employee stock options and RSAs, are recognized in the financial statements based on their respective grant date fair values. The benefits of tax deductions in excess of recognized compensation cost are reported as an operating cash flow. The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods in the Company’s statements operations. The Company has estimated the fair value of each option award as of the date of grant using the Black-Scholes option pricing model. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded. The awards issued consist of fully-vested stock awards, performance-based restricted shares, and service-based restricted shares. Expenses related to stock-based awards issued to non-employees are recognized at fair value on a recurring basis over the expected service period. The Company estimates the fair value of the awards using the Black-Scholes option pricing model.
Income taxes	Income taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability account balances are determined based on temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future pretax earnings, the reversal of temporary differences between book and tax income, and the expected tax rates in future periods. The Company has a full valuation allowance on all deferred tax assets. The Company is required to evaluate the tax positions taken in the course of preparing its tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount that is initially recognized.
Recently Issued Accounting Standards	In February 2016, the Financial Accounting Standards Board (FASB) issued ASU No. 2016-02, "Leases (Topic 842)". The amendments under this pronouncement will change the way all leases with a duration of one year of more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized like capital leases are under current accounting standards, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. This update is effective for annual reporting periods, and interim periods within those reporting periods, beginning after December 15, 2018. The Company is currently evaluating the impact this standard will have on its policies and procedures pertaining to its existing and future lease arrangements, disclosure requirements and on its consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (Topic 350), which eliminates Step 2 from the goodwill impairment test. Instead, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The Company will adopt the standard effective October 1, 2020. The adoption is not expected to have a material impact on the Company’s consolidated financial statements. In May 2014, the FASB issued a new financial accounting standard which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. ASU 2014-09 Revenue from Contracts with Customers In November 2016, the FASB issued Accounting Standards Update (ASU) 2016-18, Statement of Cash Flows In March 2016, the FASB issued Accounting Standards Update (ASU) 2016-09, Improvements to Employee Share-Based Payment Accounting

Prior Borrowing Arrangements 14

Prior Borrowing Arrangements and Restructuring Agreement (Tables)	9 Months Ended
	Sep. 30, 2017
Prior Borrowing Arrangements and Restructuring Agreement [Abstract]
Schedule of Extinguishment of Debt	Elimination of Senior Notes $ 9,405,462 Elimination of Senior Revenue Share 3,948,153 Elimination of carrying value of Patents (6,665,280) Elimination of goodwill (8,858,504) Establishment of Investment in INVT SPE 42,962,899 Gain on debt extinguishment $ 40,802,730

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2017
Stockholders Equity Note [Abstract]
Shares of common stock reserved for future issuance	Shares of common stock reserved for future issuance were as follows as of September 30, 2017: Series C Convertible Preferred Stock 3,335 Series D Convertible Preferred Stock 186,367 Series E Convertible Preferred Stock 24,364,518 Options to purchase common stock 487,528 Shares reserved for issuances pursuant to 2014 Plan (as defined below) 202,290 Warrants 11,615,849 Total 36,859,887
Redeemable Convertible preferred stock	Convertible preferred stock as of September 30, 2017 consisted of the following: Convertible Original Shares Shares Shares Liquidation Preferred Stock Issue Price Designated Originally Issued Outstanding Preference Series C $ 1,000.00 2,500 2,500 5 $ 5,000 Series D $ 1,000.00 750 369 369 $ 369,000 Series E $ 1,000.00 3,000 3,000 2,076 $ 2,076,000
Common stock warrants	Common stock warrants outstanding as of September 30, 2017 are as follows: Warrants Remaining Contractual Weighted Average Outstanding Life (years) Exercise 1,000,000 5.89 $ 0.600 6,000,000 4.03 $ 1.000 1,000,000 5.89 $ 2.005 1,271,826 3.81 $ 2.005 648,000 3.63 $ 2.01 158,416 3.62 $ 1.87 1,416,668 3.31 $ 1.79 50,000 4.41 $ 2.54 10,870 2.52 $ 4.60 5,762 2.52 $ 5.75 27,449 2.37 $ 20.00 23,858 1.33 $ 22.70 3,000 0.08 $ 26.60 11,615,849 4.20 $ 1.43

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2017
Workers Compensation Discount [Abstract]
Summary of share-based compensation activity	Common stock option and restricted stock award activity under the Plan was as follows: Options and RSAs Outstanding Shares Available Number of Weighted Average Exercise for Grant Shares Price Per Share Balance at December 31, 2016 175,046 514,772 $ 2.77 Options granted - - $ - Options forfeited - - $ - Options expired 27,244 (27,244) $ 15.80 Balance at September 30, 2017 202,290 487,528 $ 2.04 Total vested and expected to vest shares (options) 487,528 $ 2.04 Total vested shares (options) 280,742 $ 2.37
Outstanding options	The following table summarizes information with respect to stock options outstanding at September 30, 2017: Options Outstanding Options Vested Weighted- Weighted- Average Weighted- Average Exercise Remaining Average Exercise Price Per Shares Contractual Exercise Shares Price Per Share Outstanding Life (Years) Price Exercisable Share $ 1.41 305,000 8.81 $ 1.41 120,840 $ 1.41 $ 3.10 182,528 7.48 $ 3.10 159,902 $ 3.10 487,528 8.31 $ 2.04 280,742 $ 2.37
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	There were no stock options granted during the nine months ended September 30, 2017. For the nine months ended September 30, 2016, the fair value of employee stock options granted was estimated using the following weighted-average assumptions: Expected volatility 68 % Risk free rate 1.18 % Dividend yield 0 % Expected term (in years) 5.70
Schedule Of Stock Based Compensation Of Employees And Non Employees	Stock-based compensation for employees and non-employees related to options and RSAs recognized: For the three months ended Sept. 30 For the nine months ended Sept. 30 2017 2016 2017 2016 General and administrative $ 85,776 $ 152,170 $ 334,797 $ 545,626

Summary of Significant Accoun17

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Nov. 08, 2017	Dec. 31, 2016
Summary of Significant Accounting Policies [Line Items]
Working Capital Net Amount	$ 4,686,026
Retained Earnings (Accumulated Deficit), Total	(26,677,465)			$ (63,003,664)
Employee-related Liabilities, Current	1,900,000
Maintenance Costs	200,000
Other Cost and Expense, Operating	1,100,000
Proceeds from Issuance of Common Stock	0	$ 1,182,278
Estimated Capital Expenditure	3,200,000
Proceeds from Issuance of Preferred Stock and Preference Stock	0	$ 5,221,998
Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Proceeds from Issuance of Common Stock	8,100,000
eOn Communications Systems Inc [Member]
Summary of Significant Accounting Policies [Line Items]
License and Services Revenue	363,000
Convertible Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Proceeds from Issuance of Preferred Stock and Preference Stock	1,500,000
Senior Debt Agreement [Member]
Summary of Significant Accounting Policies [Line Items]
Proceeds from Lines of Credit	1,126,900
Subsequent Event [Member]
Summary of Significant Accounting Policies [Line Items]
Cash			$ 7,870
Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Proceeds from Sale of Intangible Assets	$ 7,550,000

Prior Borrowing Arrangements 18

Prior Borrowing Arrangements and Restructuring Agreement - Additional Information (Detail) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended
	Apr. 30, 2017	Oct. 01, 2014	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Borrowing Arrangements [Line Items]
Gains (Losses) on Extinguishment of Debt, Total	$ 40,802,730		$ 0	$ 0	$ 40,802,730	$ 2,434,661
Elimination of Goodwill [Member]
Borrowing Arrangements [Line Items]
Gains (Losses) on Extinguishment of Debt, Total	$ 8,858,504				$ (8,858,504)
Senior Debt Agreement [Member]
Borrowing Arrangements [Line Items]
Proceeds from Issuance of Senior Long-term Debt		$ 11,137,753
Gross Proceeds From Senior Long Term Debt		12,199,500
Proceeds from Issuance of Debt		$ 476,868
Warrants To Purchase Common Stock					50,000
Debt Instrument Restructuring Agreement, Description					(i) first, to pay for certain third party expenses incurred by the Company, the Managing Member or third party brokers in relation to the Monetization Activities, (ii) second, to pay up to $2.2 million of the Company’s outstanding principal debt to a third party from whom the Company previously purchased certain Patents, in the event any Monetization Activity is directly attributable to those certain Patents, (iii) third, if a Monetization Activity triggers a payment with respect to a retained interest owed to a party from whom the Company originally purchased the Patents, payment will be made to such prior owner, as required, (iv) fourth, to the Managing Member until the Managing Member has received (x) reimbursement of any amounts advanced by the Managing Member pursuant to the Restructuring Agreement plus 20% annual interest on such advances plus (y) $30.5 million less any amounts paid to the Managing Member for the note obligations under the Senior Debt Agreement after December 22, 2016, and (v) fifth, after all of the foregoing payment obligations are satisfied, 70% to the Managing Member and 30% to the Company.
Fortress Notes [Member]
Borrowing Arrangements [Line Items]
Debt Instrument, Description of Variable Rate Basis					LIBOR plus 7% (total interest rate of approximately 8.7% while the loan was outstanding). In addition, a 3% per annum paid-in-kind (“PIK”) interest was accrued increasing the principal amount of the Senior Notes by the amount of such interest. The PIK interest was treated as principal of the Senior Notes for all purposes of interest accrual or calculation of any premium payment. In connection with the execution of the Senior Debt Agreement, the Company paid to the Senior Lender a structuring fee equal to $385,000, which was accounted for as a discount on notes payable.

Prior Borrowing Arrangements 19

Prior Borrowing Arrangements and Restructuring Agreement (Detail) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Apr. 30, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Gains (Losses) on Extinguishment of Debt, Total	$ 40,802,730	$ 0	$ 0	$ 40,802,730	$ 2,434,661
Elimination Of Senior Note [Member]
Gains (Losses) on Extinguishment of Debt, Total				9,405,462
Elimination of Senior Revenue Share [Member]
Gains (Losses) on Extinguishment of Debt, Total				3,948,153
Elimination of carrying value of Patents [Member]
Gains (Losses) on Extinguishment of Debt, Total				(6,665,280)
Elimination of Goodwill [Member]
Gains (Losses) on Extinguishment of Debt, Total	$ 8,858,504			(8,858,504)
Establishment of Investment in INVT SPE [Member]
Gains (Losses) on Extinguishment of Debt, Total				$ 42,962,899

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail)

Oct. 12, 2016USD ($)$ / sharesshares

May 13, 2016USD ($)$ / sharesshares

Jul. 26, 2017USD ($)

Jan. 25, 2017$ / sharesshares

Jul. 21, 2016USD ($)$ / sharesshares

May 31, 2016USD ($)

May 16, 2016USD ($)$ / sharesshares

Jan. 21, 2016USD ($)$ / sharesshares

Oct. 31, 2016shares

Sep. 30, 2017USD ($)$ / sharesshares

Oct. 31, 2016USD ($)shares

Sep. 30, 2017USD ($)$ / sharesshares

Sep. 30, 2016USD ($)

Mar. 08, 2017$ / shares

Dec. 31, 2016USD ($)$ / sharesshares

Class of Stock [Line Items]

Common Stock, Shares Authorized | shares

100,000,000

100,000,000

100,000,000

Preferred Stock, Shares Authorized | shares

10,000,000

10,000,000

10,000,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

1,416,668

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 1.79

Preferred Stock, Par or Stated Value Per Share | $ / shares

$ 0.001

$ 0.001

$ 0.001

Proceeds from Issuance of Common Stock

$ 0

$ 1,182,278

Payments for Repurchase of Preferred Stock and Preference Stock

0

$ 2,500,000

Conversion Price Per Share | $ / shares

$ 1.50

Percentage of Investors Subscription Amount

85.00%

Commission Of Placement Agent, Percentage

10.00%

Commission Of Placement Agent, Value

$ 250,000

Preferred Stock, Redemption Terms

Following subsequent amendments to the Series E Purchase Agreement, the Series E Preferred Stock is redeemable at the option of the Company at 170% of the then outstanding conversion amount, and is convertible into common stock at a conversion price equal to the lesser of (a) $2.005 per share, or (b) 65% of the volume weighted average price of our common stock for ten consecutive days prior to the applicable conversion date). The Series E Purchase Agreement required the Company to hold a special meeting of stockholders to seek the approval of the holders of its common stock for the issuance of the number of shares of common stock issuable upon the conversion of the Series E Preferred Stock in excess of 19.99% of the outstanding common stock within 120 days of the execution of the Series E Purchase Agreement. The Company obtained the requisite shareholder approval on March 8, 2017.

Common Stock, Value, Issued

$ 18,608

18,608

$ 11,532

Exchange Right And Leak Out Agreement [Member]

Class of Stock [Line Items]

Common Stock, Value, Issued

$ 1,350

Description Of Exchange Agreement, Terms Of Agreement

The holders also agreed to not sell the Exchange Shares in an amount that would exceed the greater of (a) a percentage of the total trading volume on any given day and (b) $500, with an aggregate limit of 25% of total trading volume among all holders. Any sale of Exchange Shares at a price of more than $0.20 per share (the “Break-out Price”) is not subject to the agreement. The Break-out Price may be further reduced if the Company does not meet certain requirements under the agreement.

Purchase Agreement 2016 [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 2.005

Percentage Of Common Stock Purchased By Each Purchaser

100.00%

Series D Purchase Agreement [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues | shares

369

Proceeds from Contributions from Affiliates

$ 144,000

Chardan Capital Markets [Member]

Class of Stock [Line Items]

Cash Paid To Placement Agent

$ 116,932

Investor [Member]

Class of Stock [Line Items]

Legal Fees

50,000

Payments for Underwriting Expense

$ 25,000

Purchase Agreement [Member]

Class of Stock [Line Items]

Sale of Stock, Price Per Share | $ / shares

$ 2.005

Proceeds from Issuance of Common Stock

$ 1,300,000

Stock Issued During Period, Shares, New Issues | shares

648,000

Public Offering [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

6,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 1

Proceeds from Issuance or Sale of Equity

$ 6,000,000

Shares Issued, Price Per Share | $ / shares

$ 1

Sale of Stock, Number of Shares Issued in Transaction | shares

6,000,000

Proceeds from Issuance Initial Public Offering

$ 5,100,000

Payments for Repurchase of Preferred Stock and Preference Stock

1,300,000

Payments for Operating Activities

$ 3,800,000

Percentage Of Increase In Preferred Stock Redemption Premium

15.00%

July 2016 Warrants [Member]

Class of Stock [Line Items]

Reduction In Exercise Price Of Warrants | $ / shares

$ 1.43

May 2016 Warrants [Member]

Class of Stock [Line Items]

Reduction In Exercise Price Of Warrants | $ / shares

$ 1.86

Series C Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Proceeds from Issuance Initial Public Offering

$ 3,800,000

Series E Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

1,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 0.60

Preferred Stock Dividends, Income Statement Impact

$ 466,667

Stock Redeemed or Called During Period, Value

$ 2,474

Stock Redeemed or Called During Period, Shares | shares

3,837,400

Preferred Stock Redemption Premium

$ 1,363,400

Class Of Warrant Or Rights Expiration Term

5 years 6 months

Preferred Stock, Participation Rights

Pursuant to the agreement, in lieu of the conversion right as provided in the Certificate of Designation of Preferences, Rights and Limitations of the Series E Preferred Stock, each holder has the right to exchange its shares (the “Shares”) of Series E Preferred Stock for shares (the “Exchange Shares”) of the Company’s common stock at an exchange rate so that for each Share, the holder will receive a number of Exchange Shares that would yield net proceeds of $1,350 upon resale of such Exchange Share. Additionally, the holders consented to any Company non-equity linked financing or financing of its interest in INVT SPE subject to certain limitations as provided in the agreement. The holders also agreed to not sell the Exchange Shares in an amount that would exceed the greater of (a) a percentage of the total trading volume on any given day and (b) $500, with an aggregate limit of 25% of total trading volume among all holders. Any sale of Exchange Shares at a price of more than $0.20 per share (the “Break-out Price”) is not subject to the agreement. The Break-out Price may be further reduced if the Company does not meet certain requirements under the agreement.

Series C Preferred Stock [Member]

Class of Stock [Line Items]

Conversion of Stock, Description

common stock issuable upon the conversion of the Series C Preferred Stock in excess of 19.99% of the outstanding common stock and the removal of the adjustment floor within 120 days of the execution of the Series C Purchase Agreement. The Company obtained the requisite shareholder approval on June 28, 2016. Additionally, until the Series C Preferred Stock is no longer outstanding, the Series C Investors may participate in future offerings for up to 50% of the amount of such offerings.

Series C Preferred Stock [Member] | Private Placement [Member]

Class of Stock [Line Items]

Preferred Stock, Par or Stated Value Per Share | $ / shares

$ 1,000

Conversion of Stock, Shares Converted | shares

1,666,668

21

Stock Issued During Period, Shares, New Issues | shares

2,500

Stock Issued During Period, Value, New Issues

$ 2,500,000

Conversion Price Per Share | $ / shares

$ 1.50

Series E Preferred Stock [Member]

Class of Stock [Line Items]

Preferred Stock, Par or Stated Value Per Share | $ / shares

$ 1,000

Debt Instrument, Convertible, Conversion Price | $ / shares

$ 0.50

Conversion of Stock, Shares Converted | shares

1,496,262

182

Proceeds from Issuance Initial Public Offering

$ 3,000,000

Stock Issued During Period, Value, New Issues

$ 3,000,000

Conversion Price Per Share | $ / shares

$ 2.005

Preferred Stock, Redemption Terms

The Company used part of the proceeds from the sale of Series E Preferred Stock to redeem 70% of the outstanding Series C Preferred Stock. In addition, pursuant to the terms of the Series E Purchase Agreement, each of the Series C Investors was entitled to receive an additional premium such that the aggregate redemption amount is 162% of the stated value of the Series C Preferred Stock for the first 60 days after the date of the Series E Purchase Agreement and 180% thereafter.

Common Stock Dividends, Shares | shares

3,470,762

Series E Preferred Stock [Member] | Private Placement [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues | shares

3,000

Series D Preferred Stock [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares

$ 1.87

Percentage of Investors Subscription Amount

85.00%

Preferred Stock Convertible Conversion Price

1.98

Preferred Stock, Redemption Terms

The Company may redeem some or all of the Series D Preferred Stock for cash in an amount equal to 135% of the aggregate stated value then outstanding.

Series D Preferred Stock [Member] | Purchase Agreement [Member]

Class of Stock [Line Items]

Proceeds from Issuance of Convertible Preferred Stock

$ 369,000

Sale of Stock, Price Per Share | $ / shares

$ 1,000

Maximum [Member]

Class of Stock [Line Items]

Common Stock, Shares Authorized | shares

110,000,000

110,000,000

Maximum [Member] | Series E Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Preferred Stock Redemption Price Percentage

165.00%

Minimum [Member] | Series E Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Preferred Stock Redemption Price Percentage

170.00%

Stockholders' Equity (Detail)

Stockholders' Equity (Detail)	Sep. 30, 2017shares
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Options to purchase common stock	487,528
Shares reserved for issuance	36,859,887
Warrants
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Shares reserved for issuance	11,615,849
2014 Stock Plan
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Shares reserved for issuance	202,290
Series C Convertible Preferred Stock [Member]
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Convertible preferred stock	3,335
Series D Convertible Preferred Stock [Member]
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Convertible preferred stock	186,367
Series E Convertible Preferred Stock [Member]
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Convertible preferred stock	24,364,518

Stockholders' Equity (Detail 1)

Stockholders' Equity (Detail 1) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Series C Convertible Preferred Stock [Member]
Temporary Equity [Line Items]
Original Issue Price	$ 1,000
Shares Designated	2,500
Shares Originally Issued	2,500
Shares Outstanding	5
Liquidation Preference	$ 5,000	$ 5,000
Series D Convertible Preferred Stock [Member]
Temporary Equity [Line Items]
Original Issue Price	$ 1,000
Shares Designated	750
Shares Originally Issued	369
Shares Outstanding	369
Liquidation Preference	$ 369,000	369,000
Series E Convertible Preferred Stock [Member]
Temporary Equity [Line Items]
Original Issue Price	$ 1,000
Shares Designated	3,000
Shares Originally Issued	3,000
Shares Outstanding	2,076
Liquidation Preference	$ 2,076,000	$ 3,000,000

Stockholders' Equity (Detail 2)

Stockholders' Equity (Detail 2)	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	11,615,849
Remaining Contractual Life (years)	4 years 2 months 12 days
Weighted Average Exercise | $ / shares	$ 1.43
Warrant One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	1,000,000
Remaining Contractual Life (years)	5 years 10 months 20 days
Weighted Average Exercise | $ / shares	$ 0.600
Warrant Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	6,000,000
Remaining Contractual Life (years)	4 years 11 days
Weighted Average Exercise | $ / shares	$ 1
Warrant Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	1,000,000
Remaining Contractual Life (years)	5 years 10 months 20 days
Weighted Average Exercise | $ / shares	$ 2.005
Warrant Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	1,271,826
Remaining Contractual Life (years)	3 years 9 months 22 days
Weighted Average Exercise | $ / shares	$ 2.005
Warrant Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	648,000
Remaining Contractual Life (years)	3 years 7 months 17 days
Weighted Average Exercise | $ / shares	$ 2.01
Warrant Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	158,416
Remaining Contractual Life (years)	3 years 7 months 13 days
Weighted Average Exercise | $ / shares	$ 1.87
Warrant Seven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	1,416,668
Remaining Contractual Life (years)	3 years 3 months 22 days
Weighted Average Exercise | $ / shares	$ 1.79
Warrant Eight [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	50,000
Remaining Contractual Life (years)	4 years 4 months 28 days
Weighted Average Exercise | $ / shares	$ 2.54
Warrant Nine [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	10,870
Remaining Contractual Life (years)	2 years 6 months 7 days
Weighted Average Exercise | $ / shares	$ 4.60
Warrant Ten [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	5,762
Remaining Contractual Life (years)	2 years 6 months 7 days
Weighted Average Exercise | $ / shares	$ 5.75
Warrant Eleven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	27,449
Remaining Contractual Life (years)	2 years 4 months 13 days
Weighted Average Exercise | $ / shares	$ 20
Warrant Twelve [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	23,858
Remaining Contractual Life (years)	1 year 3 months 29 days
Weighted Average Exercise | $ / shares	$ 22.70
Warrant Thirteen [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding | shares	3,000
Remaining Contractual Life (years)	29 days
Weighted Average Exercise | $ / shares	$ 26.60

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended
	Jun. 30, 2016	Sep. 30, 2015	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Nov. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance			36,859,887		36,859,887
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					1,413,904
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms					The exercise price of an option cannot be less than the fair value of one share of common stock on the date of grant for incentive stock options or non-statutory stock options. The exercise price of an incentive stock option cannot be less than 110% of the fair value of one share of common stock on the date of grant for stockholders owning more than 10% of all classes of stock. Options are exercisable over periods not to exceed ten years (five years for incentive stock options granted to holders of 10% or more of the voting stock) from the grant date. Options may be granted with vesting terms as determined by the Board of Directors which generally include a one to five-year period or performance conditions or both. The pre-existing options were subsumed under the Plan.
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, options, forfeitures in period					113,388
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					148,144
2013 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition					1 year 1 month 24 days
Non-employee service share-based compensation, nonvested awards, compensation not yet recognized, stock options			$ 21,638	$ 77,672	$ 133,935	$ 297,693
Non employee service share based compensation nonvested awards total compensation cost not yet recognized period for recognition1					$ 166,562
2013 Stock Plan [Member] | Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance							360,545
2014 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Addition to Twenty Fifteen Stock Plan In Period	250,000	170,000

Stock-Based Compensation (Detai

Stock-Based Compensation (Detail)	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Options granted	1,413,904
Weighted Average Exercise Price Per share, End of year | $ / shares	$ 2.04
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Available for Grant, Beginning of year	175,046
Shares Available For Grant, Options granted	0
Shares Available For Grant, Options forfeited	0
Shares Available For Grant, Options expired	27,244
Shares Available for Grant, End of year	202,290
Number of Shares, Beginning of Year	514,772
Number of Shares, Options granted	0
Number Of Shares, Options forfeited	0
Number Of Shares, Options expired	(27,244)
Number of Shares, End of Year	487,528
Number of Shares, Total vested and expected to vest shares (options)	487,528
Number of Shares, Total vested shares (options)	280,742
Weighted Average Exercise Price Per share, Beginning of year | $ / shares	$ 2.77
Weighted Average Exercise Price Per Share, Options granted | $ / shares	0
Weighted Average Exercise Price Per Share, Options forfeited | $ / shares	0
Weighted Average Exercise Price Per Share, Options expired | $ / shares	15.8
Weighted Average Exercise Price Per share, End of year | $ / shares	2.04
Weighted Average Exercise Price Per Share, Total vested and expected to vest shares (options) | $ / shares	2.04
Weighted Average Exercise Price Per Share, Total vested shares (options) | $ / shares	$ 2.37

Stock-Based Compensation (Det26

Stock-Based Compensation (Detail 1) - $ / shares	9 Months Ended
	Sep. 30, 2017	Jan. 21, 2016
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share		$ 1.79
Outstanding Options, Shares	487,528
Outstanding Options, Weighted- Average Remaining Contractual Life (Years)	8 years 3 months 22 days
Weighted Average- Exercise Price	$ 2.04
Exercisable Options, Shares	280,742
Exercisable Options, Weighted- Average Exercise Price Per Share	$ 2.37
Range of Exercise Prices - Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 1.41
Outstanding Options, Shares	305,000
Outstanding Options, Weighted- Average Remaining Contractual Life (Years)	8 years 9 months 22 days
Weighted Average- Exercise Price	$ 1.41
Exercisable Options, Shares	120,840
Exercisable Options, Weighted- Average Exercise Price Per Share	$ 1.41
Range of Exercise Prices - Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 3.10
Outstanding Options, Shares	182,528
Outstanding Options, Weighted- Average Remaining Contractual Life (Years)	7 years 5 months 23 days
Weighted Average- Exercise Price	$ 3.10
Exercisable Options, Shares	159,902
Exercisable Options, Weighted- Average Exercise Price Per Share	$ 3.10

Stock-Based Compensation (Det27

Stock-Based Compensation (Detail 2)	9 Months Ended
	Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	68.00%
Risk free rate	1.18%
Dividend yield	0.00%
Expected term (in years)	5 years 8 months 12 days

Stock-Based Compensation (Det28

Stock-Based Compensation (Detail 3) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Operating expenses
General and administrative	$ 85,776	$ 152,170	$ 334,796	$ 545,626

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended
	Jul. 31, 2016	Dec. 31, 2016	Dec. 01, 2015	Jun. 30, 2014
Income Tax [Line Items]
Operating Loss Carryforwards		$ 55.5	$ 11.1
Deferred Tax Assets Net Operating Income Loss Carry Forwards				$ 30.4
Domestic Tax Authority [Member]
Income Tax [Line Items]
Net Operating Loss Carryforward Period Increase Decrease	$ 9.6
Foreign Tax Authority [Member]
Income Tax [Line Items]
Net Operating Loss Carryforward Period Increase Decrease	$ 5.5

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	1 Months Ended			3 Months Ended		9 Months Ended
	Jul. 31, 2017	Jul. 31, 2016	Jan. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Jul. 26, 2017	Nov. 21, 2016	Dec. 01, 2015
Commitments and Contingencies [Line Items]
Operating Leases, Rent Expense				$ 11,691	$ 27,152	$ 65,994	$ 81,455
Operating Leases, Rent Expense, Minimum Rentals	$ 1,767
Minimum Bid Price Per Share									$ 1
Required Net Capital under Commodity Exchange Act									$ 2,500,000
Statutory Accounting Practices, Requirement of Minimum Shareholders Approval,Percentage								20.00%
Guarantee Agreement Two [Member]
Commitments and Contingencies [Line Items]
Guaranteed Benefit Liability, Net				$ 2,200,000		$ 2,200,000
Debt Instrument, Interest Rate, Stated Percentage				10.00%		10.00%
Guarantee Agreement Two [Member] | January 31, 2016 [Member]
Commitments and Contingencies [Line Items]
Payments On Guaranteed Payment Liability			$ 550,000
Guarantee Agreement Two [Member] | July 1, 2016 [Member]
Commitments and Contingencies [Line Items]
Payments On Guaranteed Payment Liability		$ 1,650,000
Patents [Member] | Guarantee Agreement Two [Member]
Commitments and Contingencies [Line Items]
Guaranteed Benefit Liability, Net										$ 2,000,000